Find Clinical Trials & Studies

Visit the Research & Education Institute

A Phase 1 Dose Escalation and Expansion Study of ZG006 in Patients With Small Cell Lung Cancer

I'm Interested!

Please call
1-866-373-1464

A Phase 1 Dose Escalation Study of the Tolerability, Safety, Efficacy and Pharmacokinetics of ZG006 in Patients With Small Cell Lung Cancer

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: Cancer - Lung

Study Purpose

This is a multi-center, open-label, Phase 1 clinical study of ZG006 in the US for the treatment of subjects with small cell lung cancer who have failed or are intolerant to available standard treatment. During the dose escalation stage, a standard "3+3" design will be used to assess the MTD/ recommended dose for the subsequent studies.

Principal Investigator
Afshin Dowlati MD

Department/Division
Cancer (Thoracic)

UH IRB: STUDY20251237
StudyID: SUZH1525
ClinicalTrials.gov: NCT06592638

I'm Interested!

Please call
1-866-373-1464

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-866-373-1464